A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease. (February 2019)
- Record Type:
- Journal Article
- Title:
- A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease. (February 2019)
- Main Title:
- A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease
- Authors:
- Martini, Franciele
Rosa, Suzan Gonçalves
Klann, Isabella Pregardier
Fulco, Bruna Cruz Weber
Carvalho, Fabiano Barbosa
Rahmeier, Francine Luciano
Fernandes, Marilda Cruz
Nogueira, Cristina Wayne - Abstract:
- Abstract: Alzheimer 's disease (AD) is characterized by progressive cognitive decline including memory impairment, cortical dysfunction, and neuropsychiatric disturbances. The drug discovery to treat AD consists to develop compounds able to act in multiple molecular targets involved in the pathogenesis of the disease and the repositioning of old drugs for new application. This way, the intracerebroventricular (icv) injection of streptozotocin (STZ) has been used as a metabolic model of sporadic AD. The aim of the present study was to investigate whether ebselen (1–10 mg/kg), a multifunctional selenoorganic compound, ameliorates memory impairment, hippocampal oxidative stress, apoptosis and cell proliferation in a mouse model of sporadic AD induced by icv STZ (3 mg/kg, 1 μl/min). The administration of ebselen (10 mg/kg, i.p.) reversed memory impairment and hippocampal oxidative stress, by increasing the activities of antioxidant enzymes and the level of a non-enzymatic antioxidant defense, in Swiss mice administered with icv STZ. The anti-apoptotic property of ebselen was demonstrated by its effectiveness against the increase in the ratios of Bax/Bcl-2, cleaved PARP/PARP and the cleaved caspase-3 levels in the hippocampus of icv STZ mice. Although ebselen reversed memory impairment, it was ineffective against the reduction in the number of BrdU positive cells induced by icv STZ. In conclusion, the multifunctional selenoorganic compound ebselen was effective to reverse memoryAbstract: Alzheimer 's disease (AD) is characterized by progressive cognitive decline including memory impairment, cortical dysfunction, and neuropsychiatric disturbances. The drug discovery to treat AD consists to develop compounds able to act in multiple molecular targets involved in the pathogenesis of the disease and the repositioning of old drugs for new application. This way, the intracerebroventricular (icv) injection of streptozotocin (STZ) has been used as a metabolic model of sporadic AD. The aim of the present study was to investigate whether ebselen (1–10 mg/kg), a multifunctional selenoorganic compound, ameliorates memory impairment, hippocampal oxidative stress, apoptosis and cell proliferation in a mouse model of sporadic AD induced by icv STZ (3 mg/kg, 1 μl/min). The administration of ebselen (10 mg/kg, i.p.) reversed memory impairment and hippocampal oxidative stress, by increasing the activities of antioxidant enzymes and the level of a non-enzymatic antioxidant defense, in Swiss mice administered with icv STZ. The anti-apoptotic property of ebselen was demonstrated by its effectiveness against the increase in the ratios of Bax/Bcl-2, cleaved PARP/PARP and the cleaved caspase-3 levels in the hippocampus of icv STZ mice. Although ebselen reversed memory impairment, it was ineffective against the reduction in the number of BrdU positive cells induced by icv STZ. In conclusion, the multifunctional selenoorganic compound ebselen was effective to reverse memory impairment, hippocampal oxidative stress and apoptosis in a mouse model of sporadic AD induced by icv STZ. Highlights: Ebselen reverses memory impairment in a sporadic model of AD. Ebselen reverses apoptosis in a sporadic model of AD. Ebselen reverses oxidative stress in a sporadic model of AD. Ebselen is a multifunctional compound. … (more)
- Is Part Of:
- Journal of psychiatric research. Volume 109(2019)
- Journal:
- Journal of psychiatric research
- Issue:
- Volume 109(2019)
- Issue Display:
- Volume 109, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 109
- Issue:
- 2019
- Issue Sort Value:
- 2019-0109-2019-0000
- Page Start:
- 107
- Page End:
- 117
- Publication Date:
- 2019-02
- Subjects:
- Ebselen -- Apoptosis -- Memory -- Selenium -- Neuroprotective -- Organoselenium
Psychiatry -- Periodicals
Mental Disorders -- Periodicals
Maladies mentales -- Périodiques
Psychiatry
Electronic journals
Periodicals
616.89005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00223956 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jpsychires.2018.11.021 ↗
- Languages:
- English
- ISSNs:
- 0022-3956
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5043.250000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9293.xml